Blueprint for the development of remyelination medicines for multiple sclerosis

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)870
Number of pages1
JournalClinical Neurology
Volume50
Issue number11
DOIs
Publication statusPublished - 2010

Fingerprint

Molecular Targeted Therapy
IgG Receptors
Nerve Regeneration
Acetyltransferases
Oligodendroglia
Myelin Sheath
Multiple Sclerosis
Cell Differentiation
Chronic Disease
Transcription Factors
Lipids
Antibodies
Brain

Keywords

  • Multiple sclerosis
  • Oligodendrocyte
  • Oligodendrocyte precursor cell
  • Remyelination

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Blueprint for the development of remyelination medicines for multiple sclerosis. / Nakahara, Jin.

In: Clinical Neurology, Vol. 50, No. 11, 2010, p. 870.

Research output: Contribution to journalArticle

@article{af6eeb467f9f4ea7ae875be86081f4ee,
title = "Blueprint for the development of remyelination medicines for multiple sclerosis",
keywords = "Multiple sclerosis, Oligodendrocyte, Oligodendrocyte precursor cell, Remyelination",
author = "Jin Nakahara",
year = "2010",
doi = "10.5692/clinicalneurol.50.870",
language = "English",
volume = "50",
pages = "870",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "11",

}

TY - JOUR

T1 - Blueprint for the development of remyelination medicines for multiple sclerosis

AU - Nakahara, Jin

PY - 2010

Y1 - 2010

KW - Multiple sclerosis

KW - Oligodendrocyte

KW - Oligodendrocyte precursor cell

KW - Remyelination

UR - http://www.scopus.com/inward/record.url?scp=84856392081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856392081&partnerID=8YFLogxK

U2 - 10.5692/clinicalneurol.50.870

DO - 10.5692/clinicalneurol.50.870

M3 - Article

VL - 50

SP - 870

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 11

ER -